Showing results (901-910 of 1,089) with videos related to
Sort By:
Pageof 109
Future Oncology (London, England)|May 13, 2015
Multiparameter Phase I trials: a tool for model-based development of targeted agent combinations--example of EVESOR trialMevidette El-Madani, Emilie Hénin, Thibaud Lefort, et al.Cancer|July 1, 2021
Patients, caregivers, and clinicians differ in performance status ratings: Implications for pediatric cancer clinical trialsScott H Maurer, Pamela S Hinds, Bryce B Reeve, et al.Aging|December 7, 2015
Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO studyClaire Falandry, Béatrice Horard, Amandine Bruyas, et al.BMC Research Notes|July 5, 2015
Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methodsAurélie Bourmaud, Emilie Henin, Fabien Tinquaut, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2014
Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivorsSaro H Armenian, Sarah K Gelehrter, Tabitha Vase, et al.Nature Communications|December 23, 2024
Preventing excessive autophagy protects from the pathology of mtDNA mutations in Drosophila melanogasterNajla El Fissi, Florian A Rosenberger, Kai Chang, et al.Journal of the National Cancer Institute|January 22, 2023
Risk of early death in adolescents and young adults with cancer: a population-based studyAmy M Berkman, Clark R Andersen, Michelle A T Hildebrandt, et al.European Heart Journal. Digital Health|September 23, 2025
Gender specific aspects of digital screening for atrial fibrillation: insights from the randomized eBRAVE-AF trialLuisa Freyer, Peter Spielbichler, Lukas von Stülpnagel, et al.BMC Cancer|November 10, 2011
Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costsFlorence Ranchon, Gilles Salles, Hans-Martin Späth, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 8, 2007
Open, reconfigurable cytometric acquisition system: ORCASMark A Naivar, Jimmie D Parson, Mark E Wilder, et al.Pageof 109